Substituted piperazines are common motifs in a large number of compounds with biological activity. Furthermore, N-urea and N,N’-bis-urea piperazine derivatives have interesting antiviral properties as well as attributes for other therapeutic indications. Unsymmetrical substituted piperazine derivatives require monoprotected piperazines, which can be tedious to prepare and expensive. Furthermore, their use calls for an additional deprotection step. Herein we propose N-methylpiperazine for the preparation of unsymmetrical derivatives containing at least one N-urea moiety as a substitute of the piperazine core. The methyl group acts as protecting group of one of the nitrogen atoms of the piperazine and is concomitantly removed during the formation of a synthetic intermediate. In one of our ongoing research programs devoted to the development of novel proton acceptor immonium-type coupling reagents, we address the preparation of aminium chlorides, shown in Figure 1. Although the reaction of N,N-dimethylmorpholine-4-carboxamide and N,N-dimethylthiomorpholine-4carboxamide with bistrichloromethyl carbonate (BTC) or phosgene rendered the corresponding oxygenand sulfur-containing aminium salts, this result was not achieved if N,N-4-trimethylpiperazine-1-carboxamide was used. Thus, reaction of this compound with BTC followed by the addition of potassium benzotriazolate (KOBt) or potassium 7-azabenzotriazolate (KOAt) (Figure 1, left), a pure white solid was obtained. This product showed a H NMR spectrum similar to that expected (aromatic region from the OBt/OAt and protons from the piperazine cycle and dimethylamino group), but with a distinct molecular weight, as determined by MS, and with extra C NMR signals (2 carbonyls) and one missing CH3 (N-CH3). Xray crystallography (Figure 2) confirmed that the product was active carbamate piperazine 1.